ADVANCED VENOUS ACCESS M3L9FHKI NA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2001-05-04 for ADVANCED VENOUS ACCESS M3L9FHKI NA manufactured by Edwards Lifesciences.

Event Text Entries

[21257667] It was reported that blood was filling the contamination shield during open cardiac chest massage. It was reported that the patient later expired. The relationship of the device to the patient's expiration is unknown.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6000002-2001-00162
MDR Report Key330797
Report Source05
Date Received2001-05-04
Date of Report2001-04-04
Report Date2001-04-04
Date Mfgr Received2001-04-04
Date Added to Maude2001-05-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactALLISON MEZZANATTO
Manufacturer StreetONE EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal92614
Manufacturer Phone9492502562
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVANCED VENOUS ACCESS
Generic NameCENTRAL VENOUS CATHETER
Product CodeJCY
Date Received2001-05-04
Model NumberM3L9FHKI
Catalog NumberNA
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeUNKNOWN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key320159
ManufacturerEDWARDS LIFESCIENCES
Manufacturer AddressROAD 402 NORTH KM 1.0 ANASCO PR 00610 US
Baseline Brand NameADVANCED VENOUS ACCESS (AVA) CATHETER
Baseline Generic NameCENTRAL VENOUS ACCESS CATHETER
Baseline Model NoM3L9FHKI
Baseline Catalog NoNA
Baseline IDNA
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]18
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK981909
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2001-05-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.